openPR Logo
Press release

Global Biosimulation Market Size Projected to Value over $5 Billion by 2026 end

04-08-2019 02:30 PM CET | Health & Medicine

Press release from: FutureWise Research

Biosimulation Market

Biosimulation Market

Discovering and producing a lifesaving drug formula is a high-priced process. If the drug molecule fails at the last stage of development it can ruin efforts, time and money. This forged the need to develop a predictive tool that could foretell outcomes of drug development by simulating biological process to treat the desired ailment. This need serves as a significant catalyst in the growth of biosimulation market for the coming years.

What is Biosimulation?

Simulation of a biological process using computer aid and algorithms refers to Biosimulation. It supports the model-based prediction of dynamics of biological systems, for instance, the response of a single cell towards a substantial say in case of diabetic ailments.
Advancement in biosimulation technologies, increase in healthcare expenditures and computer intelligence development contribute to additional factors other than the need for a predictive tool as aforementioned. The Global biosimulation market size is forecasted to reach over $5 billion by 2026 end from $1.65 billion in 2018. Thus it is estimated to register a CAGR o15.6% during the forecast period of 2019-2026. The biosimulation market can be categorised by product type, service type, end-users, and region.
Pharmaceutical manufacturers, healthcare regulatory bodies and research organizations are actively investing in research and development of drug discovery by utilising biosimulation techniques for augmenting the efficacy of drug discovery and development process. Hence accelerated drug discovery process by these end users is one of the major drivers in biosimulation market growth. The goal to detect early sign of disease along with an overwhelming burden of genetic disorders leads to an increase in research funding in gene therapy. This implies higher chances of adoption of biosimulation products and services during the forecasted period.

Request a sample copy of this report @

North America to Dominate the Market
North America leads the market in terms of revenue due to factors such as high usage of personalized medicine, growth in the biotechnology and pharmaceutical industry, ongoing drug development processes, increasing R&D expenditure by pharmaceutical and biotechnology organisations. Europe holds the second position amongst dominating markets followed by the Asia Pacific region.

Higher cost efficiency is one of the reasons for a surge in demand for biosimulation services. Contract services segment is expected to exhibit growth at a significant CAGR during the forecast period.

Biosimulation provides information regarding dose precision, predicting drug safety, drug interaction on a molecular level and PBPK(physiologically-based pharmacokinetic) modelling using sophisticated pharmacodynamics models of the vital organs like heart, liver, and other organisms. Advanced simulation and instrumented tools offer high-fidelity, realistic, and immersive insights by combining cloud-based approach with simulation platforms (like Simcyp) and data visualization software using virtual patient population. Besides mergers and acquisitions among major players, the market exhibits promising lucrative progression trends during the forecast period.

For more information about Biosimulation Market @

Report Structure

Global Biosimulation Market, by Product Type
• Contract Services
• Software
• In House
• Molecular Simulation
Global Biosimulation Market, by Service Type
• Subscription-based Services
• Ownership
Global Biosimulation Market, by End-User
• Biopharmaceutical Companies
• Contract Research Organization
• Academic Institutes
Global Biosimulation Market, by Region
• Europe
• North America
• Latin America
• Rest of World
Competitive Landscape
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

To browse through our range of reports in the Healthcare and Life Science industry, refer to the following link @

Objectives of the Study

• To provide with an exhaustive analysis on the global biosimulation market, by service type, by end-user, and region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Get unlimited analyst support and customise this study further to your requirements, contact

About Us:

FutureWise Research & Consulting was created with the vision of empowering decision-makers with the market intelligence they need most. In an era inundated with numbers, we provide clarity. Filtering through the noise, we present insights and analyses into markets, industries and the competition, allowing companies to focus their resources towards effective strategising.

Contact Us:

City West Business Park
Gelderd Rd, Leeds LS12 6LN,
Phone: +44 141 628 9353
Email Id:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Biosimulation Market Size Projected to Value over $5 Billion by 2026 end here

News-ID: 1693265 • Views: 535

More Releases from FutureWise Research

Unit Drug Dose Delivery System Market Global Trends, Market Share, Industry Size …
Global Unit Drug Dose Delivery System Market is poised to register a CAGR of over 5% during the forecast period of 2019 to 2026. Patients have to receive accurate dosing of drugs which will improve the recovery rate of the patient hence unit drug delivery system is implemented by hospitals and clinics. This system is also efficient in maintaining drug storage and its disposal. These are some of the primary factors that
Vascular Sealing Systems Market Global Trends, Market Share, Industry Size, Grow …
Global vascular sealing systems market predicted to value over USD 1 billion by 2026 end and register a CAGR over 6% during the forecast period 2019 to 2026.  The number of patients experiencing cardiovascular disease (CVD) are on a rise due to lack of physical activity, high blood pressure, changing lifestyle, addictions like alcohol consumption and smoking. According to the American Heart Association, CVD is the leading cause for mortality worldwide,
Implantable Pulse Generator Market Global Trends, Market Share, Industry Size, G …
A rise in various complex diseases and medical conditions has led the healthcare sector to push research and development boundaries which have resulted in a new age of disease treatment and one such technology is Implantable Pulse Generator (IPG). It is a micro-electronic medical device which is battery-powered that is inserted in the body where the nervous system is delivered with an electric stimulation which helps in stimulation or blocking
Hospital Acquired Pneumonia Treatment Market Global Trends, Market Share, Indust …
The global hospital acquired pneumonia treatment market is estimated to value over US$ 1.5 billion with a CAGR of 3% during the forecast period, 2019 to 2026 In the recent past, the public healthcare system is facing a difficult challenge in the form of Hospital Acquired Pneumonia (HAP). It is a type of pneumonia when a person is hospitalized for more than 48 hours. In pneumonia, the lungs are conditioned to an inflammatory

All 5 Releases

More Releases for Biosimulation

Global Biosimulation Market to witness digitized satiation
In the process of biosimulation, the computer aided mathematical models are used to simulate the biological processes. Biosimulation is an important part of systems biology and helps in the discovery and development of new drugs, in the area of drug metabolism and in the modeling of biomedical systems that are complex. There is a growing demand for reduction in the cost of discovery of new drugs and the risk of failure
The Biosimulation Market to Be Driven By Neurotechnology
The Biosimulation Market is slated to grow unstoppably in the years to come. The healthcare providers are, of late, making way for more specialized and timely treatment through same-day surgeries, outpatient surgeries, and likewise. ASCs (Ambulatory Surgical Centers) are preferred over conventional hospital settings. As such, cost-effective medical services could be provided. This type of customization is expected to take the healthcare vertical by storm in the future. In the process
The Biosimulation Market to stick to digitized innovation
The Biosimulation Market taught to grow sporadically shortly. With improvement in machine-powered analytics, the healthcare vertical is bound to substantiate therein. Machine learning does make caregivers able of putting data to use, thereby enhancing patients’ outcomes along with overall efficiency. This would be the trend in the healthcare vertical going forward. Get Sample Copy of this Report@ In the process of biosimulation, the computer aided mathematical models are used to simulate
Biosimulation Market Study: An Emerging Hint of Opportunity
Latest released the research study on Global Biosimulation Market, offers a detailed overview of the factors influencing the global business scope. Biosimulation Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Biosimulation. The study covers emerging player’s data, including: Certara, L.P., Simulations Plus,
Biosimulation Market Growth and Sales Forecast 2016 - 2014
Global Biosimulation Market: Overview Biosimulation refers to the mathematical simulation of biological processes and systems. It is aided by computer and is used for model based calculation of biological systems and processes. TMR’s latest report forecasts strong growth for the global biosimulation market between 2011 and 2018. The market is expected to significantly gain from the increasing use of pharmacokinetic (PKPD) and pharmacodynamics, of which PKPD is the most widely used
Biosimulation Market Size, Industry Analysis & Forecast Report 2017
Biosimulation Market Outlook To 2024 has added the report, “Biosimulation Market Outlook To 2024: Key Categories (Software, Services), by Application, by End-Use, Regional Segmentation, Pipeline Analysis, Competitive Dynamics, And Segment Forecast” extend across over 103 pages, the far reaching research study offers a 360-degree analysis of the market crosswise over different unequivocal elements, including market share by segmentation type, cost analysis, market effect factors, and marketing strategy and promoting methodology. The